bioAffinity Technologies Statistics
Total Valuation
BIAF has a market cap or net worth of $9.13 million. The enterprise value is $9.56 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025, before market open.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BIAF has 17.91 million shares outstanding. The number of shares has increased by 38.61% in one year.
| Current Share Class | 17.91M |
| Shares Outstanding | 17.91M |
| Shares Change (YoY) | +38.61% |
| Shares Change (QoQ) | +19.34% |
| Owned by Insiders (%) | 21.46% |
| Owned by Institutions (%) | 8.49% |
| Float | 14.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | 0.96 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 21.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.58.
| Current Ratio | 0.87 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -96.82 |
Financial Efficiency
Return on equity (ROE) is -242.44% and return on invested capital (ROIC) is -106.21%.
| Return on Equity (ROE) | -242.44% |
| Return on Assets (ROA) | -75.95% |
| Return on Invested Capital (ROIC) | -106.21% |
| Return on Capital Employed (ROCE) | -262.66% |
| Revenue Per Employee | $164,246 |
| Profits Per Employee | -$158,594 |
| Employee Count | 57 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 259.63 |
Taxes
In the past 12 months, BIAF has paid $11,650 in taxes.
| Income Tax | 11,650 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.31% in the last 52 weeks. The beta is 3.47, so BIAF's price volatility has been higher than the market average.
| Beta (5Y) | 3.47 |
| 52-Week Price Change | -80.31% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 49.43 |
| Average Volume (20 Days) | 28,517,127 |
Short Selling Information
The latest short interest is 250,918, so 1.40% of the outstanding shares have been sold short.
| Short Interest | 250,918 |
| Short Previous Month | 239,795 |
| Short % of Shares Out | 1.40% |
| Short % of Float | 1.78% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, BIAF had revenue of $9.36 million and -$9.04 million in losses. Loss per share was -$0.75.
| Revenue | 9.36M |
| Gross Profit | 3.38M |
| Operating Income | -8.95M |
| Pretax Income | -8.35M |
| Net Income | -9.04M |
| EBITDA | -8.35M |
| EBIT | -8.95M |
| Loss Per Share | -$0.75 |
Full Income StatementBalance Sheet
The company has $1.11 million in cash and $1.50 million in debt, giving a net cash position of -$395,903 or -$0.02 per share.
| Cash & Cash Equivalents | 1.11M |
| Total Debt | 1.50M |
| Net Cash | -395,903 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 2.60M |
| Book Value Per Share | 0.17 |
| Working Capital | -409,807 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.26 million and capital expenditures -$79,083, giving a free cash flow of -$7.34 million.
| Operating Cash Flow | -7.26M |
| Capital Expenditures | -79,083 |
| Free Cash Flow | -7.34M |
| FCF Per Share | -$0.41 |
Full Cash Flow StatementMargins
Gross margin is 36.09%, with operating and profit margins of -95.64% and -96.56%.
| Gross Margin | 36.09% |
| Operating Margin | -95.64% |
| Pretax Margin | -96.43% |
| Profit Margin | -96.56% |
| EBITDA Margin | -89.17% |
| EBIT Margin | -95.64% |
| FCF Margin | n/a |